Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hydroquinidine Displays a Significant Anti-carcinogenic Activity in Breast and Ovarian Cancer Cells via Inhibiting Cell-cycle and Stimulating Apoptosis

1 Jan 2023

Abstract excerpt

Breast and ovarian cancers are women's most commonly diagnosed cancers. Seeking an efficient anticarcinogenic compound is still a top priority regarding the aggressiveness of these cancers and the limited benefit of current therapies. Hydroquinidine (HQ) is a natural alkaloid used in arrhythmia and Brugada syndrome. As an ion channel blocker, HQ exhibits its activity by altering ion gradient and membrane...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 protein interactions
Share to Microbial Natural Products and Biosynthesis
Share to Synthesis and Biological Evaluation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37529110
DOI: 10.55730/1300-0152.2640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hydroquinidine Displays a Significant Anti-carcinogenic Activity in Breast and Ovarian Cancer Cells via Inhibiting Cell-cycle and Stimulating ApoptosisPMID 37529110Read ↗

Cytotoxic activity, apoptosis induction and cell cycle arrest in human breast cancer (MCF7) cells by a novel fluorinated tetrahydro-[1,2,4]triazolo[3,4-a]isoquinolin chalconesSemantic proximity Read ↗

Isoquinolines alkaloids and cancer metabolism: Pathways and targets to novel chemotherapySemantic proximity Read ↗

A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancerSemantic proximity Read ↗

Deciphering the Dose-Dependent Effects of Thymoquinone on Transcriptomic Changes and Cellular Proliferation in GlioblastomaSemantic proximity Read ↗

Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype.Semantic proximity Read ↗

A quinoline-2-thione derivative as a novel chemotherapy drug candidate displays anti-tumor activity in vitro and in vivoSemantic proximity Read ↗

THE CYTOTOXIC EFFECT OF BENZOIC ACID ON TEN DIFFERENT CANCER CELL LINESSemantic proximity Read ↗

Discovery of Dihydropyrrol-2-ones as Novel G0/G1-Phase Arresting Agents Inducing ApoptosisSemantic proximity Read ↗

Investigation of Key Molecular Mechanisms of 6PPDQ in Breast Cancer Development and Progression through Network Toxicology and Computational SimulationSemantic proximity Read ↗

BRD4770 protects against DOX-induced cardiotoxicity by inhibiting apoptosis and ferroptosisSemantic proximity Read ↗

Hydroxychloroquine Induces Apoptosis in Cholangiocarcinoma via Reactive Oxygen Species Accumulation Induced by Autophagy InhibitionSemantic proximity Read ↗

Multi-Target Inhibition of Hepatocellular Carcinoma via DIBP from Glycyrrhiza uralensis: A Systems Biology and Experimental ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.